Tinavi Medical Technologies Co., Ltd. (688277) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tinavi Medical Technologies Co., Ltd.

Why is Tinavi Medical Technologies Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

Poor long term growth as Net Sales has grown by an annual rate of 13.49% and Operating profit at -10.80% over the last 5 years

Flat results in Sep 25

OPERATING PROFIT(Q) Lowest at CNY -55.61 MM
OPERATING PROFIT MARGIN(Q) Lowest at -89.45 %
PRE-TAX PROFIT(Q) Lowest at CNY -53.81 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 77.29%, its profits have risen by 16%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tinavi Medical Technologies Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Tinavi Medical Technologies Co., Ltd.

72.1%

3.97

57.58%

China Shanghai Composite

13.33%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

13.49%

EBIT Growth (5y)

-10.80%

EBIT to Interest (avg)

-47.41

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.05

Sales to Capital Employed (avg)

0.14

Tax Ratio

22.35%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.21

EV to EBIT

-52.06

EV to EBITDA

-75.74

EV to Capital Employed

6.60

EV to Sales

31.72

PEG Ratio

Dividend Yield

ROCE (Latest)

-12.67%

ROE (Latest)

-11.17%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

NET SALES(Q)

At CNY 62.16 MM has Grown at 83.88%

OPERATING CASH FLOW(Y)

Highest at CNY -12.16 MM

NET PROFIT(HY)

Higher at CNY -103.7 MM

RAW MATERIAL COST(Y)

Fallen by -57.21% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.76 times

DEBTORS TURNOVER RATIO(HY)

Highest at 4.5 times

-18What is not working for the Company

OPERATING PROFIT(Q)

Lowest at CNY -55.61 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -89.45 %

PRE-TAX PROFIT(Q)

Lowest at CNY -53.81 MM

NET PROFIT(Q)

Lowest at CNY -59.09 MM

EPS(Q)

Lowest at CNY -0.12

Here's what is working for Tinavi Medical Technologies Co., Ltd.

Net Sales

At CNY 62.16 MM has Grown at 83.88%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely positive

Net Sales (CNY MM)

Operating Cash Flow

Highest at CNY -12.16 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio

Highest at 2.76 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 4.5 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -57.21% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tinavi Medical Technologies Co., Ltd.

Net Profit

At CNY -59.09 MM has Fallen at -99.04%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Pre-Tax Profit

At CNY -53.81 MM has Fallen at -45.78%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Operating Profit

Lowest at CNY -55.61 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -89.45 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at CNY -53.81 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY -59.09 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY -0.12

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)